Related Experiment Video
Updated: Jan 28, 2026

Efficient iPS Cell Generation from Blood Using Episomes and HDAC Inhibitors
Published on: October 28, 2014
An Overview of HDAC Inhibitors and their Synthetic Routes
Xiaopeng Peng1,2, Guochao Liao3, Pinghua Sun4
1School of Pharmaceutical Sciences, Guangdong Provincial Key Laboratory of New Drug Screening, Southern Medical University, Guangzhou 510515, China.
Abstract:
Epigenetics play a key role in the origin, development and metastasis of cancer. Epigenetic processes include DNA methylation, histone acetylation, histone methylation, and histone phosphorylation, among which, histone acetylation is the most common one that plays important roles in the regulation of normal cellular processes, and is controlled by histone deacetylases (HDACs) and histone acetyltransferases (HATs). HDACs are involved in the regulation of many key cellular processes, such as DNA damage repair, cell cycle control, autophagy, metabolism, senescence and chaperone function, and can lead to oncogene activation. As a result, HDACs are considered to be an excellent target for anti-cancer therapeutics like histone deacetylase inhibitors (HDACi) which have attracted much attention in the last decade. A wide-ranging knowledge of the role of HDACs in tumorigenesis, and of the action of HDACi, has been achieved. The primary purpose of this paper is to summarize recent HDAC inhibitors and the synthetic routes as well as to discuss the direction for the future development of new HDAC inhibitors.
Insights
Histone deacetylases (HDACs) are crucial in cancer development. This review summarizes recent histone deacetylase inhibitors (HDACi) and discusses future directions for novel anti-cancer therapeutics.
Area of Science:
- Oncology
- Epigenetics
- Biochemistry
Background:
- Epigenetic modifications, including histone acetylation, are vital in cancer initiation, progression, and metastasis.
- Histone deacetylases (HDACs) regulate critical cellular functions like DNA repair and cell cycle control, and their dysregulation can activate oncogenes.
- Histone deacetylase inhibitors (HDACi) have emerged as promising anti-cancer therapeutics due to the critical role of HDACs in tumorigenesis.
Purpose of the Study:
- To provide a comprehensive summary of recent advancements in histone deacetylase inhibitors (HDACi).
- To review the synthetic routes employed in the development of novel HDAC inhibitors.
- To discuss future perspectives and potential directions for the development of new anti-cancer HDACi.
Main Methods:
- Literature review of recent studies on HDAC inhibitors.
- Analysis of synthetic pathways for HDAC inhibitor development.
- Discussion of current research trends and future prospects in HDAC inhibitor therapy.
Main Results:
- Significant progress has been made in understanding the role of HDACs in cancer.
- Numerous HDAC inhibitors have been developed, with ongoing research into their synthesis and efficacy.
- The therapeutic potential of HDACi in various cancers is increasingly recognized.
Conclusions:
- HDACs are validated targets for cancer therapy, with HDACi showing considerable promise.
- Continued research into novel HDAC inhibitors and their synthetic routes is essential for advancing cancer treatment.
- Future development should focus on optimizing HDACi for improved efficacy and targeted delivery in anti-cancer strategies.
More Related Videos
Related Concept Videos
Routes of Drug Administration: Overview
Enteral administration refers to drugs absorbed through the gastrointestinal tract. They can be swallowed (perorally), placed under the tongue (sublingually), or on the inner lining of the cheeks (buccally). Perorally administered drugs take time to be absorbed and have a slower onset of action. The rectal route is another form of enteral administration, which allows for...
Routes of Persuasion
Eukaryotic Transcription Inhibitors
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
Synthetic Biology
Golden rice
Golden rice is a genetically modified...
Drug Delivery: Enteral Route
Drug Delivery: Parenteral Route
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...

